Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2).

Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2). Support Care Cancer. 2020 Feb; 28(2):571-579.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Chemotherapy-Induced Febrile Neutropenia
Cyclophosphamide
Doxorubicin
Female
Filgrastim
Granulocyte Colony-Stimulating Factor
Humans
Incidence
Japan
Male
Middle Aged
Polyethylene Glycols
Prednisone
Retrospective Studies
Risk Factors
Rituximab
Vincristine

authors with profiles

Yuko Mishima